The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on: March 13,2024 15

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on:March 13,2024 15

Researchers publish cell protein findings to determine effectiveness of immunotherapy for colon cancer

by Kelley Luckstein,Mayo ClinicCredit: CC0 Public DomainMayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patien

Updated on: February 01,2024 15

Researchers publish cell protein findings to determine effectiveness of immunotherapy for colon cancer

by Kelley Luckstein,Mayo ClinicCredit: CC0 Public DomainMayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patien

Updated on:February 01,2024 15

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,

Updated on: April 01,2024 15

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,

Updated on:April 01,2024 15

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on: April 01,2024 18

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on:April 01,2024 18

Artificial intelligence tool developed to predict risk of lung cancer

byMassachusetts General HospitalCredit: CC0 Public DomainLung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is

Updated on: January 02,2024 10

Artificial intelligence tool developed to predict risk of lung cancer

byMassachusetts General HospitalCredit: CC0 Public DomainLung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is

Updated on:January 02,2024 10

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red

Updated on: January 13,2024 18

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red

Updated on:January 13,2024 18

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on: January 22,2024 10

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on:January 22,2024 10

CAR-T immunotherapy could be improved to kill solid tumors

by Thomas Jefferson UniversityCancer cell during cell division. Credit: National Institutes of HealthImmunotherapy, which harnesses the power of the body's immune system to fight disease, is

Updated on: April 09,2024 15

CAR-T immunotherapy could be improved to kill solid tumors

by Thomas Jefferson UniversityCancer cell during cell division. Credit: National Institutes of HealthImmunotherapy, which harnesses the power of the body's immune system to fight disease, is

Updated on:April 09,2024 15

Researchers invent a new class of AI to improve cancer research and treatments

by Colette Gallagher,Mayo ClinicCredit: Mayo ClinicMayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a signifi

Updated on: March 20,2024 14

Researchers invent a new class of AI to improve cancer research and treatments

by Colette Gallagher,Mayo ClinicCredit: Mayo ClinicMayo Clinic researchers recently invented a new class of artificial intelligence (AI) algorithms called hypothesis-driven AI that are a signifi

Updated on:March 20,2024 14

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on: February 23,2024 18

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on:February 23,2024 18

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024 19

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024 19

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on: March 01,2024 15

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on:March 01,2024 15